Literature DB >> 15674423

Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines.

Y Ding1, Z Li, J D Broome.   

Abstract

In common with certain other lymphoid neoplasms, cells of the human lymphocytic leukemia lines 1873 and 1929 are asparagine (ASN) auxotrophs. Asparagine synthetase (ASY), which is a housekeeping gene, is repressed and the promoting region of the gene is highly methylated. We now demonstrate in these cells multiple levels in control of the expression of this gene, in a system of cocultivation with macrophages and other cell types. In this system, mediated by cell-to-cell contact, ASY becomes expressed by the leukemic cells and they become prototrophic. Demethylation of ASY occurs; it follows expression and is permanent over multiple cell generations, but the cells return to auxotrophy with rapid repression of ASY on removal from cell contact. With ASY expression, the associated histone H3 at lysine position 9 (H3K9) becomes acetylated and H3K4, methylated. In contrast to other systems, H3K9 methylation does not characterize the repressed state. The changes leading from repression to induction of ASY and demethylation parallel the physiological changes specific to functional maturation of normal lymphoid precursors. The lability of expression of ASY has potential significance in determining the sensitivity of leukemic cells to L-asparaginase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15674423     DOI: 10.1038/sj.leu.2403639

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  12 in total

1.  Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.

Authors:  Jean Hugues Parmentier; Maristella Maggi; Erika Tarasco; Claudia Scotti; Vassilios I Avramis; Steven D Mittelman
Journal:  Leuk Res       Date:  2015-04-22       Impact factor: 3.156

Review 2.  Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

Authors:  Xavier Thomas; Caroline Le Jeune
Journal:  Int J Hematol Oncol       Date:  2016-05-05

3.  Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.

Authors:  Wai-Kin Chan; Thomas D Horvath; Lin Tan; Todd Link; Karine G Harutyunyan; Michael A Pontikos; Andriy Anishkin; Di Du; Leona A Martin; Eric Yin; Susan B Rempe; Sergei Sukharev; Marina Konopleva; John N Weinstein; Philip L Lorenzi
Journal:  Mol Cancer Ther       Date:  2019-06-17       Impact factor: 6.261

4.  Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

Authors:  Shotaro Iwamoto; Keichiro Mihara; James R Downing; Ching-Hon Pui; Dario Campana
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

5.  Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.

Authors:  Ehsan A Ehsanipour; Xia Sheng; James W Behan; Xingchao Wang; Anna Butturini; Vassilios I Avramis; Steven D Mittelman
Journal:  Cancer Res       Date:  2013-04-12       Impact factor: 12.701

6.  Cell-cycle inhibition by Helicobacter pylori L-asparaginase.

Authors:  Claudia Scotti; Patrizia Sommi; Maria Valentina Pasquetto; Donata Cappelletti; Simona Stivala; Paola Mignosi; Monica Savio; Laurent Roberto Chiarelli; Giovanna Valentini; Victor M Bolanos-Garcia; Douglas Scott Merrell; Silvia Franchini; Maria Luisa Verona; Cristina Bolis; Enrico Solcia; Rachele Manca; Diego Franciotta; Andrea Casasco; Paola Filipazzi; Elisabetta Zardini; Vanio Vannini
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

Review 7.  Asparagine synthetase: regulation by cell stress and involvement in tumor biology.

Authors:  Mukundh N Balasubramanian; Elizabeth A Butterworth; Michael S Kilberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

Review 8.  Drugging the addict: non-oncogene addiction as a target for cancer therapy.

Authors:  Remco Nagel; Ekaterina A Semenova; Anton Berns
Journal:  EMBO Rep       Date:  2016-10-04       Impact factor: 8.807

9.  Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells.

Authors:  Sophia Ceder; Sofi E Eriksson; Ying Yu Liang; Emarndeena H Cheteh; Si Min Zhang; Kenji M Fujihara; Julie Bianchi; Vladimir J N Bykov; Lars Abrahmsen; Nicholas J Clemons; Pär Nordlund; Sean G Rudd; Klas G Wiman
Journal:  Cell Death Dis       Date:  2021-07-15       Impact factor: 9.685

Review 10.  Asparagine: A Metabolite to Be Targeted in Cancers.

Authors:  Jie Jiang; Sandeep Batra; Ji Zhang
Journal:  Metabolites       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.